Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 24, 2019 08:30 ET | Source: Fluidigm Corporation

Fluidigm Becomes the First Company to Enable 50-Plex Cytometry Panels with the Release of Seven New Metal Antibody Labels

SOUTH SAN FRANCISCO, Calif., Sept. 24, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
September 18, 2019 08:30 ET | Source: Fluidigm Corporation

CyTOF Inventors Receive Prestigious Science and Technology Award from the Human Proteome Organization (HUPO)

SOUTH SAN FRANCISCO, Calif., Sept. 18, 2019 (GLOBE NEWSWIRE) -- The Human Proteome Organization (HUPO), an international scientific organization that promotes proteomics through international...
September 10, 2019 07:30 ET | Source: Fluidigm Corporation

Fluidigm Files Patent Infringement Suit Against IONpath

SOUTH SAN FRANCISCO, Calif., Sept. 10, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
September 09, 2019 08:30 ET | Source: Fluidigm Corporation

Fluidigm Revolutionizes Next-Generation Sequencing RNA Library Preparation with Microfluidic Automation

SOUTH SAN FRANCISCO, Calif., Sept. 09, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
September 04, 2019 08:30 ET | Source: Fluidigm Corporation

Fluidigm Launches Imaging Mass Cytometry Immuno-Oncology Panel Kits and Advanced CyTOF Software at the 2019 World Molecular Imaging Congress (WMIC)

SOUTH SAN FRANCISCO, Calif., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), the global leader in highly multiplexed single-scan tissue imaging, today announced the launch of...
August 27, 2019 08:30 ET | Source: Fluidigm Corporation

Fluidigm and the Icahn School of Medicine at Mount Sinai Collaborate on Landmark Single-Cell Study of the Human Epigenome

SOUTH SAN FRANCISCO, Calif., Aug. 27, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
August 20, 2019 16:05 ET | Source: Fluidigm Corporation

Fluidigm to Participate in Upcoming Health Care Investor Conferences

SOUTH SAN FRANCISCO, Calif., Aug. 20, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
August 02, 2019 00:41 ET | Source: Fluidigm Corporation

CORRECTING and REPLACING - Fluidigm Announces Second Quarter 2019 Financial Results

Second Quarter Revenue Increased 7 Percent to $28.2 Million Mass Cytometry Revenue Growth of 28 Percent in Second Quarter Expansion of Mass Cytometry Products with New Metal Markers and Imaging Mass...
August 01, 2019 16:05 ET | Source: Fluidigm Corporation

Fluidigm Announces Second Quarter 2019 Financial Results

Second Quarter Revenue Increased 7 Percent to $28.2 Million Mass Cytometry Revenue Growth of 28 Percent in Second Quarter Expansion of Mass Cytometry Products with New Metal Markers and Imaging Mass...
August 01, 2019 16:01 ET | Source: Fluidigm Corporation

Jonathan Day Named VP, Commercial Operations, Americas

SOUTH SAN FRANCISCO, Calif., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced the appointment of Jonathan Day as Vice President, Commercial Operations, Americas. ...